Jan 17
|
When Should You Buy The Joint Corp. (NASDAQ:JYNT)?
|
Jan 16
|
The Joint Corp. Reports 2024 Operating Metrics
|
Dec 31
|
With 46% stake, The Joint Corp. (NASDAQ:JYNT) seems to have captured institutional investors' interest
|
Oct 10
|
The Joint Chiropractic Ranks No. 150 on the Franchise Times Top 400
|
Oct 9
|
The Joint Corp (JYNT) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges
|
Oct 8
|
The Joint Chiropractic Celebrates 25 Years of Making Quality Chiropractic Care Accessible
|
Aug 16
|
The Joint (JYNT) Forays Into San Francisco Chiropractic Market
|
Aug 13
|
The Joint Chiropractic Opens First Location in San Francisco
|
Aug 10
|
Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?
|
Aug 10
|
Joint Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
Jul 25
|
The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results
|
Jul 24
|
The Joint Corp. (NASDAQ:JYNT) has caught the attention of institutional investors who hold a sizeable 48% stake
|
Jun 27
|
Joint (NASDAQ:JYNT) Will Be Hoping To Turn Its Returns On Capital Around
|
May 13
|
The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts
|
May 7
|
The Joint Corp. to Participate in Upcoming Investor Conferences
|
May 6
|
The Joint Corp. (NASDAQ:JYNT) Q1 2024 Earnings Call Transcript
|
May 4
|
Is The Joint Corp. (NASDAQ:JYNT) Trading At A 48% Discount?
|
May 4
|
Joint First Quarter 2024 Earnings: EPS Beats Expectations
|
May 2
|
The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates
|
May 2
|
The Joint Corp (JYNT) Q1 2024 Earnings: Revenue Grows, Surpassing Analyst Projections
|